过去一年中添加的文章,按日期排序

Randomized trials of PSA screening

P Dave, SV Carlsson, K Watts - Urologic Oncology: Seminars and Original …, 2024 - Elsevier
12 天前 - … a screening intervention arm compared to no screening to determine the effect of
PSA screening on prostate cancer mortalityrandomized trial of PSA testing for prostate cancer (…

Prostate Cancer Knowledge, Attitudes, and Beliefs amongst Women: The Application of a Psychometrically Valid Tool (PCaKAB‐Gh) in a Large Population

E Wiafe, KB Mensah, N Padayachee… - European Journal of …, 2024 - Wiley Online Library
13 天前 - … Amongst the 2000 study participants who … to screen for prostate cancer,” “prostate
cancer screening must be free for every man,” and “men diagnosed with prostate cancer must …

Causality of genetically determined metabolites on susceptibility to prevalent urological cancers: A two-sample Mendelian randomization study and meta-analysis

X Dai, H Wang, R Zhong, J Li, Y Hou - Frontiers in Genetics - frontiersin.org
23 天前 - Frontiers | Causality of genetically determined metabolites on susceptibility to
prevalent urological cancers: A two-sample Mendelian randomization study and meta-analysis …

Prostate cancer screening-current overview

M De Vrieze, A Hübner, R Al-Monajjed… - Radiologie …, 2024 - europepmc.org
54 天前 - … review, we present a current overview of the body of evidence on prostate cancer
screening with a focus on the role of magnetic resonance imaging (MRI) of the prostate. …

Which men benefit from prostate cancer screening? Prostate cancer mortality by subgroup in the European Randomised Study of Screening for Prostate Cancer

N Pasanen, K Talala, S Remmers… - BJU …, 2024 - Wiley Online Library
59 天前 - study was based on three European Randomised Study of Screening for Prostate
Cancer (… We identified 126 827 men aged 55–69 years in the study who were followed for …

Cancer stage compared with mortality as end points in randomized clinical trials of cancer screening: a systematic review and meta-analysis

X Feng, H Zahed, J Onwuka, MEJ Callister… - JAMA, 2024 - jamanetwork.com
91 天前 - … included 41 randomized clinical trials of cancer screening conducted in Europe,
North … Data extracted included numbers of participants, cancer diagnoses, and cancer deaths

[引用][C] A Pilot Study of 68Ga-PSMA-11 PET/MRI and 68Ga-RM2 PET/MRI for Biopsy Guidance in Patients with Suspected Prostate Cancer

Cost-effectiveness analysis of prostate cancer screening and MRI

T Takahashi - World Journal of Urology, 2024 - Springer
93 天前 - … that PSA screening does not contribute to a reduction in overall mortality, providing
a … These facts suggest that even if cancer mortality is averted, other-cause mortality would …

Abstract B051: Genome-wide association studies of 26,187 women without ovarian cancer identifies 12 genetic loci of blood CA125

N Sasamoto, J Kim, C Turman, SS Tworoger, R Kaaks… - Cancer Research, 2024 - AACR
125 天前 - cancer and is the single best ovarian cancer screening biomarker candidate to date,
although two randomized screening … difference in ovarian cancer mortality. Consideration …

[HTML][HTML] … for Two Dose Strengths of Niraparib and Abiraterone Acetate Dual-Action Tablets Versus Single Agents: Utility of Clinical Study Data Supplemented with …

A Yu, A Hazra, JJ Jiao, P Hellemans, A Mitselos… - Clinical …, 2024 - Springer
125 天前 - Prostate cancer is the most commonly diagnosed cancer … and 375,000 associated
deaths globally in 2020 [1]. While … prostate cancer is increasing because of early detection